NO20021251L - Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendbare som D4antagonister - Google Patents

Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendbare som D4antagonister

Info

Publication number
NO20021251L
NO20021251L NO20021251A NO20021251A NO20021251L NO 20021251 L NO20021251 L NO 20021251L NO 20021251 A NO20021251 A NO 20021251A NO 20021251 A NO20021251 A NO 20021251A NO 20021251 L NO20021251 L NO 20021251L
Authority
NO
Norway
Prior art keywords
thienylpyrrazolyl
antagonists
compounds
tienoisoxazolyl
substituted propyl
Prior art date
Application number
NO20021251A
Other languages
English (en)
Norwegian (no)
Other versions
NO20021251D0 (no
Inventor
David M Fink
Brian Scott Freed
Nicholas Joseph Hrib
Jr Raymond Walter Kosley
George E Lee
Gregory Harold Merriman
Barbara Seavey Rauckman
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20021251D0 publication Critical patent/NO20021251D0/no
Publication of NO20021251L publication Critical patent/NO20021251L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20021251A 1999-09-14 2002-03-13 Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendbare som D4antagonister NO20021251L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39608199A 1999-09-14 1999-09-14
PCT/US2000/024962 WO2001019833A1 (en) 1999-09-14 2000-09-13 Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists

Publications (2)

Publication Number Publication Date
NO20021251D0 NO20021251D0 (no) 2002-03-13
NO20021251L true NO20021251L (no) 2002-05-10

Family

ID=23565772

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021251A NO20021251L (no) 1999-09-14 2002-03-13 Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendbare som D4antagonister

Country Status (26)

Country Link
EP (1) EP1216250B1 (de)
JP (1) JP4847662B2 (de)
KR (1) KR20020027647A (de)
AR (1) AR032134A1 (de)
AT (1) ATE254621T1 (de)
AU (1) AU7577400A (de)
BR (1) BR0014515A (de)
CA (1) CA2383340C (de)
CY (1) CY1101692T1 (de)
CZ (1) CZ2002897A3 (de)
DE (1) DE60006699T2 (de)
DK (1) DK1216250T3 (de)
EA (1) EA200200355A1 (de)
EE (1) EE200200135A (de)
ES (1) ES2209995T3 (de)
HR (1) HRP20020220A2 (de)
HU (1) HUP0203526A3 (de)
IL (1) IL148623A0 (de)
MX (1) MXPA02002695A (de)
NO (1) NO20021251L (de)
PL (1) PL354515A1 (de)
PT (1) PT1216250E (de)
SK (1) SK3512002A3 (de)
TW (1) TW530060B (de)
WO (1) WO2001019833A1 (de)
ZA (1) ZA200201762B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
EP1688412A3 (de) * 2001-02-16 2006-08-16 Aventis Pharmaceuticals, Inc. Neue heterocyclische Amide-Derivate und ihre Verwendung als dopamine D3-Rezeptor-Liganden
WO2002083648A1 (fr) * 2001-04-16 2002-10-24 Eisai Co., Ltd. Nouveau compose a base de 1h-indazole
KR20040020457A (ko) * 2002-08-30 2004-03-09 주식회사 대웅 3-｛2-[4-(6-플루오로벤조[ｄ]이속사졸-3-일)피페리디노]에틸｝-2-메틸-6,7,8,9-테트라하이드로-4Ｈ-피리도[1,2-ａ]피리미딘-4-온 또는 그 산부가염의 제조방법
AU2004209522A1 (en) * 2003-01-17 2004-08-19 Gilead Palo Alto, Inc. Substituted heterocyclic compounds useful in the treatment of cardiovascular diseases
JP2007297321A (ja) * 2006-04-28 2007-11-15 Daiso Co Ltd アリール２−メチルグリシジルエーテル類の製造法
JP2007297330A (ja) * 2006-04-28 2007-11-15 Daiso Co Ltd ２−メチルグリシジル誘導体の製造法
JP2016505597A (ja) 2012-12-21 2016-02-25 エピザイム，インコーポレイティド Ｐｒｍｔ５阻害剤およびその使用
US9745291B2 (en) 2012-12-21 2017-08-29 Epizyme, Inc. PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
US9908887B2 (en) 2012-12-21 2018-03-06 Epizyme, Inc. PRMT5 inhibitors and uses thereof
US8993555B2 (en) 2012-12-21 2015-03-31 Epizyme, Inc. PRMT5 inhibitors and uses thereof
WO2014100716A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
WO2015200680A2 (en) * 2014-06-25 2015-12-30 Epizyme, Inc. Prmt5 inhibitors and uses thereof
US10653693B2 (en) 2014-08-04 2020-05-19 Epizyme, Inc. PRMT5 inhibitors and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728651A (en) * 1985-10-24 1988-03-01 Hoechst-Roussel Pharmaceuticals Inc. Antihypertensive thieno-isoxazoles and -pyrazoles
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
HUP9603001A3 (en) * 1996-10-30 1999-07-28 Richter Gedeon Vegyeszet Heterocycle compounds comprising nitrogen, process for producing them and pharmaceutical compositions containing the same
ATE367389T1 (de) * 1998-02-09 2007-08-15 Duphar Int Res Benzisoxazolderivate mit d4-antagonistischer wirkung

Also Published As

Publication number Publication date
DK1216250T3 (da) 2004-02-23
CA2383340C (en) 2010-06-15
JP4847662B2 (ja) 2011-12-28
AR032134A1 (es) 2003-10-29
EE200200135A (et) 2003-04-15
ATE254621T1 (de) 2003-12-15
NO20021251D0 (no) 2002-03-13
MXPA02002695A (es) 2002-07-30
ES2209995T3 (es) 2004-07-01
IL148623A0 (en) 2002-09-12
JP2003509432A (ja) 2003-03-11
KR20020027647A (ko) 2002-04-13
DE60006699T2 (de) 2004-09-30
EP1216250A1 (de) 2002-06-26
DE60006699D1 (en) 2003-12-24
HUP0203526A2 (hu) 2003-01-28
PT1216250E (pt) 2004-04-30
BR0014515A (pt) 2002-06-25
TW530060B (en) 2003-05-01
WO2001019833A1 (en) 2001-03-22
CA2383340A1 (en) 2001-03-22
EA200200355A1 (ru) 2002-10-31
PL354515A1 (en) 2004-01-26
CZ2002897A3 (cs) 2002-07-17
ZA200201762B (en) 2003-08-27
HUP0203526A3 (en) 2004-12-28
AU7577400A (en) 2001-04-17
HRP20020220A2 (en) 2004-02-29
EP1216250B1 (de) 2003-11-19
CY1101692T1 (el) 2010-07-28
SK3512002A3 (en) 2003-03-04

Similar Documents

Publication Publication Date Title
WO2008156713A3 (en) Anti-cd20 therapeutic compositions and methods
CL2008001960A1 (es) Compuestos derivados de tetrahidropiranocromano, procedimiento de preparacion, composicion farmaceutica, util para inhibir gamma-secretasa, destinados al tratamiento de enfermedades neurodegenetarivas, enfermedad de alzheimer e inhibir el deposito de proteina amiloide.
WO2007014238A8 (en) Single dose use of cd20-specific binding molecules
WO2006073973A3 (en) Novel benzylamine derivatives as cetp inhibitors
MY150088A (en) Immunosuppressant compounds and compositions
WO2005019179A3 (en) Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases
WO2006064453A3 (en) Targeting agents for molecular imaging
WO2006102557A3 (en) Treatment of protein degradation disorders
WO2008070111A3 (en) Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
WO2004009062A3 (en) NMDA RECEPTOR ANTAGONISTS AND THEIR USE IN INHIBITING ABNORMAL HYPERPHOSPHORYLATION OF MICROTUBULE ASSOCIATED PROTEIN tau
GB0621244D0 (en) Methods and compositions for treatment of ion imbalances
WO2007109799A3 (en) Polymorphs of eszopiclone malate
WO2004106322A3 (en) Polymorphs of aripiprazole
MXPA02002695A (es) Derivados de propilo tienoisoxazolil- y tienilpirrazolil-fenoxi sustituidos utiles como antagonistas de d4.
WO2010000089A8 (en) Stat3 and tyk2 as drug targets for neurodegenerative diseases
DE60004543D1 (de) Benzisoxazolyl-, pyridoisoxazolyl- und benzthienyl-phenoxy derivate als d4 antagonisten
WO2005054172A3 (en) Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof
WO2005085188A3 (en) Compounds and methods for anti-tumor therapy
WO2006042137A3 (en) Methods for identifying parkinson's disease therapeutics
GB0504103D0 (en) Novel method
WO2005092062A3 (en) Compounds for neurodegenerative disorders
WO2006016219A3 (en) Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
WO2001019832A3 (en) Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
UA87292C2 (ru) Применение сирамезина для лечения злокачественных опухолей
WO2005107748A3 (en) Method of tonic treatment with oxyphenbutazone derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application